DOTSON JERROLD DUANE
SEC CIK 1388853 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | VP, CFO AND Sec | 3,671 | — | $93.9K | 8 | 2021-06-30 | 2023-06-30 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
DOTSON JERROLD DUANE made no open-market trades at VTGN in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-06-30 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO | A - Grant | $1.59 | +167 | 3,671 | +5% | +$265.53 | |
| 2023-01-03 | 2022-12-30 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $0.09 | +5,000 | 105.1K | +5% | +$450 | |
| 2022-07-15 | 2022-07-30 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $0.75 | +5,000 | 100.1K | +5% | +$3,750 | |
| D | 2022-01-12 | 2022-01-11 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $1.00 | +18.8K | 94.6K | +25% | +$18.8K |
| 2022-01-03 | 2021-12-31 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $1.66 | +3,575 | 75.8K | +5% | +$5,934 | |
| 2021-09-08 | 2021-09-07 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | S - Sale | $3.13 | -30.0K | 72.8K | -29% | -$93.9K | |
| DM | 2021-07-02 | 2021-06-30 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $0.9399 | +89.7K | 14.0K | New | +$84.3K |
| D | 2021-07-02 | 2021-06-30 | VTGN | Vistagen Therapeutics, Inc. | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $1.95 | +3,044 | 13.0K | +30% | +$5,936 |
Purchase Sale Sale after option exercise All abbreviations